Curcumin targets FOLFOX-surviving colon cancer cells via inhibition of EGFRs and IGF-1R. [electronic resource]
Producer: 20100504Description: 319-25 p. digitalISSN:- 1791-7530
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Blotting, Western
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Colonic Neoplasms -- drug therapy
- Curcumin -- administration & dosage
- ErbB Receptors -- antagonists & inhibitors
- Fluorouracil -- administration & dosage
- Humans
- Organoplatinum Compounds -- administration & dosage
- Oxaliplatin
- RNA, Small Interfering -- pharmacology
- Receptor, IGF Type 1 -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.